Hong Kong – Regulatory Collaboration

Singapore's Health Sciences Authority (HSA) and the Department of Health (DoH), Hong Kong Special Administrative Region (HKSAR) signed a Memorandum of Understanding (MOU) for cooperation in healthcare regulatory matters pertaining to health products, on 13 August 2025. This MOU marks an important milestone in strengthening ties between the two regulatory authorities.

The MOU encompasses technical cooperation and mutual exchange of information, best practices and expertise pertaining to healthcare regulatory matters across a broad spectrum of health products, including pharmaceuticals, medical devices, advanced therapy products and traditional medicines. The agreement also facilitates the sharing of regulatory information and enforcement approaches towards tobacco products and vaping devices. To support these objectives, the MOU enables exchange of regulatory experts and staff, participation in meetings and scientific conferences, as well as collaboration in training courses and joint projects.

This collaboration underscores Singapore and Hong Kong’s shared commitment to ensuring the safety, quality and efficacy of health products and to advancing regulatory excellence in our jurisdictions.